Science.gov

Sample records for balantidiasis

  1. Balantidiasis in a dromedarian camel

    PubMed Central

    Tajik, Javad; Fard, Saeid R Nourollahi; paidar, Amin; Anousheh, Samaneh; Dehghani, Elahe

    2013-01-01

    A 3 years old male dromedarian camel was examined because of anorexia and diarrhea. The affected camel was depressed, tachycardic, eupnic, and had a body temperature of 38.8 °C. Mucous membranes were hyperemic and faeces was soft and mucous coated but of normal colour and odour. Faecal examination revealed a large number of Balantidium coli trophozoites and cysts (15 000/g) and no other parasite could be detected in faecal sample. Seven days after the onset of treatment using intramuscular antibiotic (ampicillin) and anti inflammatory agent (flunixin meglumine), the food consumption, clinical signs and faecal consistency were normal, and faecal examination revealed no parasite. Presence of no other pathogen in faecal samples, and concurrent disappearance of clinical signs and absence of the parasite in the faeces confirmed a diagnosis of balantidiasis. There are only two previous reports about the balantidiasis in camel and the current report is the first report of camel balantidiasis in Iran and supports the proposed role of camels as a reservoir host for Balantidium coli in Iran.

  2. Balantidiasis

    DTIC Science & Technology

    2011-06-01

    metronidazole (500 mg 2 times/day for 5 days); other drugs such as ampicillin, car- basone, diodoquin, nitrimidazine, and paromomycin have been used...coli acquired in France. Eur J Clin Microbiol Infect Dis. 2004;23:393-395. 22. Garcia-Laverde A, de Bonilla L. Clinical trials with metronidazole in

  3. Urinary balantidiasis: A rare incidental finding in a patient with chronic obstructive pulmonary disease

    PubMed Central

    Kaur, Sukhpreet; Gupta, Avinash

    2016-01-01

    Balantidiasis is a rare zoonotic disease in humans. Balantidium coli is the causative ciliated protozoan. We present a case of urinary balantidiasis in a patient having chronic obstructive pulmonary disease (COPD) who was on steroids for a long time. He has no symptoms of bowel or urinary involvement. We are reporting this case because of its rarity in human urine and also for future references. PMID:27756993

  4. Prevalence, hematology, and treatment of balantidiasis among donkeys in and around Lahore, Pakistan.

    PubMed

    Khan, A; Khan, M S; Avais, M; Ijaz, M; Ali, M M; Abbas, T

    2013-09-01

    The prevalence of Balantidium coli among donkeys in Lahore and adjoining areas was surveyed and a trial conducted to determine the efficacy of two antiprotozoal drugs: secnidazole (Dysen Forte) and Kalonji (Nigella sativa). Four-hundred donkeys were examined, and 73 (18.3%) were found positive for Balantidium coli. A slight decrease in PCV and an increase in Hb values of infected donkeys were found after antiprotozoal treatment. Secnidazole was 89.5% effective for the treatment of equine balantidiasis compared to 40.0% for Nigella sativa. This is the first report of balantidiasis in equines from Pakistan. It is not known if balantidiasis is an emerging problem in equines or whether it is a newly reported infection.

  5. Discrepancies in the occurrence of Balantidium coli between wild and captive African great apes.

    PubMed

    Pomajbíková, Kateřina; Petrželková, Klára J; Profousová, Ilona; Petrášová, Jana; Modrý, David

    2010-12-01

    Balantidium coli is a ciliate reported in many mammalian species, including African great apes. In the former, asymptomatic infections as well as clinical balantidiasis have been reported in captivity. We carried out a cross-sectional study of B. coli in African great apes (chimpanzees, bonobos, and both species of gorillas) and examined 1,161 fecal samples from 28 captive facilities in Europe, plus 2 sanctuaries and 11 wild sites in Africa. Samples were analyzed with the use of Sheather's flotation and merthiolate-iodine-formaldehyde (MIFC) sedimentation. MIFC sedimentation was the more sensitive technique for diagnostics of B. coli in apes. Although not detected in any wild-ape populations, B. coli was diagnosed in 52.6% of captive individuals. Surprisingly, in the apes' feces, trophozoites of B. coli were commonly detected, in contrast with other animals, e.g., Old World monkeys, pigs, etc. Most likely reservoirs for B. coli in captive apes include synantropic rats. High starch diets in captive apes are likely to exacerbate the occurrence of balantidiasis in captive apes.

  6. Parasitic Colitis

    PubMed Central

    Hechenbleikner, Elizabeth M.; McQuade, Jennifer A.

    2015-01-01

    Over one billion people worldwide harbor intestinal parasites. Parasitic intestinal infections have a predilection for developing countries due to overcrowding and poor sanitation but are also found in developed nations, such as the United States, particularly in immigrants or in the setting of sporadic outbreaks. Although the majority of people are asymptomatically colonized with parasites, the clinical presentation can range from mild abdominal discomfort or diarrhea to serious complications, such as perforation or bleeding. Protozoa and helminths (worms) are the two major classes of intestinal parasites. Protozoal intestinal infections include cryptosporidiosis, cystoisosporiasis, cyclosporiasis, balantidiasis, giardiasis, amebiasis, and Chagas disease, while helminth infections include ascariasis, trichuriasis, strongyloidiasis, enterobiasis, and schistosomiasis. Intestinal parasites are predominantly small intestine pathogens but the large intestine is also frequently involved. This article highlights important aspects of parasitic infections of the colon including epidemiology, transmission, symptoms, and diagnostic methods as well as appropriate medical and surgical treatment. PMID:26034403

  7. Preliminary Insights into the Impact of Dietary Starch on the Ciliate, Neobalantidium coli, in Captive Chimpanzees

    PubMed Central

    Procházka, Petr; Modrý, David; Bolechová, Petra; Petrželková, Klára J.

    2013-01-01

    Infections caused by the intestinal ciliate Neobalantidium coli are asymptomatic in most hosts. In humans and captive African great apes clinical infections occasionally occur, manifested mainly by dysentery; however, factors responsible for development of clinical balantidiasis have not been fully clarified. We studied the effect of dietary starch on the intensities of infection by N. coli in two groups of captive chimpanzees. Adult chimpanzees infected by N. coli from the Hodonín Zoo and from the Brno Zoo, Czech Republic, were fed with a high starch diet (HSD) (average 14.7% of starch) for 14 days, followed by a five-day transition period and subsequently with a period of low starch diet (LoSD) (average 0.1% of starch) for another 14 days. We collected fecal samples during the last seven days of HSD and LoSD and fixed them in 10% formalin. We quantified trophozoites of N. coli using the FLOTAC method. The numbers of N. coli trophozoites were higher during the HSD (mean ± SD: 49.0±134.7) than during the LoSD (3.5±6.8). A generalized linear mixed-effects model revealed significantly lower numbers of the N. coli trophozoites in the feces during the LoSD period in comparison to the HSD period (treatment contrast LoSD vs. HSD: 2.7±0.06 (SE), z = 47.7; p<<0.001). We conclude that our data provide a first indication that starch-rich diet might be responsible for high intensities of infection of N. coli in captive individuals and might predispose them for clinically manifested balantidiasis. We discuss the potential nutritional modifications to host diets that can be implemented in part to control N. coli infections. PMID:24282589

  8. Neglected Tropical Diseases of Oceania: Review of Their Prevalence, Distribution, and Opportunities for Control

    PubMed Central

    Kline, Kevin; McCarthy, James S.; Pearson, Mark; Loukas, Alex; Hotez, Peter J.

    2013-01-01

    Among Oceania's population of 35 million people, the greatest number living in poverty currently live in Papua New Guinea (PNG), Fiji, Vanuatu, and the Solomon Islands. These impoverished populations are at high risk for selected NTDs, including Necator americanus hookworm infection, strongyloidiasis, lymphatic filariasis (LF), balantidiasis, yaws, trachoma, leprosy, and scabies, in addition to outbreaks of dengue and other arboviral infections including Japanese encephalitis virus infection. PNG stands out for having the largest number of cases and highest prevalence for most of these NTDs. However, Australia's Aboriginal population also suffers from a range of significant NTDs. Through the Pacific Programme to Eliminate Lymphatic Filariasis, enormous strides have been made in eliminating LF in Oceania through programs of mass drug administration (MDA), although LF remains widespread in PNG. There are opportunities to scale up MDA for PNG's major NTDs, which could be accomplished through an integrated package that combines albendazole, ivermectin, diethylcarbamazine, and azithromycin, in a program of national control. Australia's Aboriginal population may benefit from appropriately integrated MDA into primary health care systems. Several emerging viral NTDs remain important threats to the region. PMID:23383349

  9. Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control.

    PubMed

    Kline, Kevin; McCarthy, James S; Pearson, Mark; Loukas, Alex; Hotez, Peter J

    2013-01-01

    Among Oceania's population of 35 million people, the greatest number living in poverty currently live in Papua New Guinea (PNG), Fiji, Vanuatu, and the Solomon Islands. These impoverished populations are at high risk for selected NTDs, including Necator americanus hookworm infection, strongyloidiasis, lymphatic filariasis (LF), balantidiasis, yaws, trachoma, leprosy, and scabies, in addition to outbreaks of dengue and other arboviral infections including Japanese encephalitis virus infection. PNG stands out for having the largest number of cases and highest prevalence for most of these NTDs. However, Australia's Aboriginal population also suffers from a range of significant NTDs. Through the Pacific Programme to Eliminate Lymphatic Filariasis, enormous strides have been made in eliminating LF in Oceania through programs of mass drug administration (MDA), although LF remains widespread in PNG. There are opportunities to scale up MDA for PNG's major NTDs, which could be accomplished through an integrated package that combines albendazole, ivermectin, diethylcarbamazine, and azithromycin, in a program of national control. Australia's Aboriginal population may benefit from appropriately integrated MDA into primary health care systems. Several emerging viral NTDs remain important threats to the region.